NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

NXTM 16.26 -0.41 (-2.46%)
price chart
NxStage Medical (NXTM) Shares Cross Below 200 DMA
In trading on Tuesday, shares of NxStage Medical Inc (Symbol: NXTM) crossed below their 200 day moving average of $16.39, changing hands as low as $16.20 per share.
Insider Trade: Joseph Turk Sold 1500 Shares of NxStage Medical, Inc ...
Joseph Turk, the well informed man, who's the present President of NxStage Medical, Inc. (NASDAQ:NXTM) 16.67 -0.14 -0.83% sold around 1,500 shares of the company that are worth about $27,510 USD based on an avg price of 18.3 USD of a share.
Warning NxStage Medical, Inc. (NASDAQ:NXTM) optimists! Joseph Turk just ...
As revealed in an electronic form that was filled with the DC-based SEC on 22/04/2015, Joseph Turk, President of NxStage Medical, Inc. (NASDAQ:NXTM) 16.67 -0.14 -0.83% and a well informed person, unloaded 1,950 shares of the firm for about $35,880 ...
NxStage Medical President Joseph E. Turk, Jr. Sells 1950 Shares (NXTM)  Dakota Financial News
NxStage Medical CEO Sells $180800.00 in Stock (NXTM)  The Legacy
The Insider Jeffrey Burbank Sold 10000 shares of NxStage Medical, Inc ...
The insider, and NxStage Medical, Inc. (NASDAQ:NXTM) 16.87 +0.36 2.17% 's Chief Executive Officer, Jeffrey Burbank, unloaded 10,000 company shares on 13-05-2015, worth approximately $164,400 (at $16.4 a share).
NxStage Medical Inc. (NXTM) is Trading Higher on Unusual Volume for May 12  Equities.com
Earnings in Focus: NxStage Medical, Inc. (NASDAQ:NXTM)  Markets Daily
Why NxStage Medical Inc. Stock Surged Higher
Why it's happening: For the quarter, NxStage Medical reported a 13% increase in revenue to a record $75.3 million, which happened to be higher than the prior guidance issued by the company of $71 million-$72.5 million issued during its second-quarter ...
Related articles »  
Winifred Swan, an Insider in NxStage Medical, Inc. (NASDAQ:NXTM), Unloaded ...
500 shares of NxStage Medical, Inc. (NASDAQ:NXTM) 16.67 -0.14 -0.83% were unloaded by Winifred Swan, the corporation's SVP and General Counsel.
NxStage Medical CEO Jeffrey H. Burbank Sells 10000 Shares (NXTM)  The Legacy
Friday's Morning Outlook: 500.com Limited (WBAI), Nxstage Medical, Inc ...  WallStreet Scope
Sell-side Focus: NxStage Medical, Inc. (NASDAQ:NXTM)
The consensus EPS estimate that analysts have on NxStage Medical, Inc. (NASDAQ:NXTM) for the quarter ending 2015-06-30 is $-0.1.
Brokerages Expect NxStage Medical to Post ($0.10) EPS (NASDAQ:NXTM)  sleekmoney
NxStage Medical Loss Narrower than Expected, Revenues Up
Manufacturer of innovative dialysis products, NxStage Medical Inc. (NXTM - Snapshot Report), reported adjusted loss of 9 cents per share in the first quarter of 2015, narrower than the Zacks Consensus Estimate of loss of 11 cents.
NxStage Medical Loss Narrower than Expected, Revenues Up - Analyst Blog  Nasdaq
Insider Selling: NxStage Medical SVP Sells $41625.00 in Stock (NXTM)
NxStage Medical logo NxStage Medical (NASDAQ:NXTM) SVP Winifred L. Swan sold 2,500 shares of the company's stock on the open market in a transaction dated Monday, May 18th. The shares were sold at an average price of $16.65, for a total ...
Stock Update - NxStage Medical, Inc. (NASDAQ:NXTM)
NxStage Medical, Inc. (NASDAQ:NXTM) shares closed the last trading session at 16.51. In the current trading session the stock reached as high as 17.08 and dipped down to 16.55.
Insider Selling: NxStage Medical SVP Winifred L. Swan Sells 2500 Shares of ...  The Legacy
NxStage Announces First Annual Zenith Award Winner  MarketWatch